Abstract
Intestinal fibrosis is a common and potentially serious complication of IBD that results from the reaction of intestinal tissue to the damage inflicted by chronic inflammation. The traditional view that fibrosis is inevitable or irreversible in patients with IBD is progressively changing in light of improved understanding of the cellular and molecular mechanisms that underlie the pathogenesis of fibrosis in general, and, in particular, intestinal fibrosis. These mechanisms are complex and dynamic, and involve multiple cell types, interconnected cellular events and a large number of soluble factors. In addition, owing to a breakdown of the epithelial barrier during inflammation of the gut, luminal bacterial products induce an innate immune response, which is triggered by activation of immune and nonimmune cells alike. Comprehension of the mechanisms of intestinal fibrosis will create a conceptual and practical framework that could achieve the specific blockade of fibrogenic pathways, allow for the estimation of risk of fibrotic complications, permit the detection of early fibrotic changes and, eventually, enable the development of treatments customized to the type and stage of each patient's IBD.
Key Points
-
Intestinal fibrosis is a common complication of IBD and represents a response of mesenchymal cells to injuries inflicted by chronic inflammatory insults
-
In addition to fibroblasts, several other cell types contribute to intestinal fibrosis, including stellate cells, bone marrow-derived cells, fibrocytes and pericytes
-
Events such as epithelial-to-mesenchymal and endothelial-to-mesenchymal transitions contribute to fibrosis
-
A large number of soluble factors present in IBD-affected tissue mediate intestinal fibrosis, among which transforming growth factor β1, interleukin 13, selected chemokines and proteolytic enzymes predominate
-
The enteric, commensal microbiota contribute to intestinal fibrosis by inciting an innate immune response mediated by immune and nonimmune cells
-
Experimental evidence indicates that blockade of selective signaling pathways can prevent or reverse fibrosis; therefore, intestinal fibrosis should not be considered an inevitable or irreversible component of chronic inflammation
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Silverstein, M. D. et al. Clinical course and costs of care for Crohn's disease: Markov model analysis of a population-based cohort. Gastroenterology 117, 49–57 (1999).
Louis, E. et al. Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the disease. Gut 49, 777–782 (2001).
Cosnes, J. et al. Impact of the increasing use of immunosuppressants in Crohn's disease on the need for intestinal surgery. Gut 54, 237–241 (2005).
Powell, D. W. et al. Myofibroblasts. I. Paracrine cells important in health and disease. Am. J. Physiol. 277, C1–C19 (1999).
Pucilowska, J. B. et al. Fibrogenesis. IV. Fibrosis and inflammatory bowel disease: cellular mediators and animal models. Am. J. Physiol. Gastrointest. Liver Physiol. 279, G653–G659 (2000).
Lawrance, I. C. et al. Altered response of intestinal mucosal fibroblasts to profibrogenic cytokines in inflammatory bowel disease. Inflamm. Bowel Dis. 7, 226–236 (2001).
Simmons, J. G. et al. IGF-I and TGF-beta1 have distinct effects on phenotype and proliferation of intestinal fibroblasts. Am. J. Physiol. Gastrointest. Liver Physiol. 283, G809–G818 (2002).
Vallance, B. A. et al. TGF-beta1 gene transfer to the mouse colon leads to intestinal fibrosis. Am. J. Physiol. Gastrointest. Liver Physiol. 289, G116–G128 (2005).
Burke, J. P. et al. Transcriptomic analysis of intestinal fibrosis-associated gene expression in response to medical therapy in Crohn's disease. Inflamm. Bowel Dis. 14, 1197–1204 (2008).
Berton, A. et al. Activation of fibroblasts in collagen lattices by mast-cell extract: a model of fibrosis. Clin. Exp. Allergy 30, 485–492 (2000).
Xu, X. et al. Mast cells and eosinophils have a potential profibrogenic role in Crohn disease. Scand. J. Gastroenterol. 39, 440–447 (2004).
Leeb, S. N. et al. Autocrine fibronectin-induced migration of human colonic fibroblasts. Am. J. Gastroenterol. 99, 335–340 (2004).
Leeb, S. N. et al. Regulation of migration of human colonic myofibroblasts. Growth Factors 20, 81–91 (2002).
Leeb, S. N. et al. Reduced migration of fibroblasts in inflammatory bowel disease: role of inflammatory mediators and focal adhesion kinase. Gastroenterology 125, 1341–1354 (2003).
Knittel, T. et al. Rat liver myofibroblasts and hepatic stellate cells: different cell populations of the fibroblast lineage with fibrogenic potential. Gastroenterology 117, 1205–1221 (1999).
Apte, M. V. et al. Pancreatic stellate cells are activated by proinflammatory cytokines: implications for pancreatic fibrogenesis. Gut 44, 534–541 (1999).
Leite, A. Z. et al. Isolation and functional characterization of human intestinal mucosal stellate cells [Abstract]. Gastroenterology 122, A-111 (S830).
Lin, W. R. et al. The role of bone marrow-derived cells in fibrosis. Cells Tissues Organs 188, 178–188 (2002).
Brittan, M. et al. A regenerative role for bone marrow following experimental colitis: contribution to neovasculogenesis and myofibroblasts. Gastroenterology 128, 1984–1995 (2005).
Bamba, S. et al. Bone marrow transplantation ameliorates pathology in interleukin-10 knockout colitic mice. J. Pathol. 209, 265–273 (2006).
Bellini, A. & Mattoli, S. The role of the fibrocyte, a bone marrow-derived mesenchymal progenitor, in reactive and reparative fibroses. Lab. Invest. 87, 858–870 (2007).
Quan, T. E. et al. Circulating fibrocytes: collagen-secreting cells of the peripheral blood. Int. J. Biochem. Cell Biol. 36, 598–606 (2004).
Gordon, S. & Taylor, P. R. Monocyte and macrophage heterogeneity. Nat. Rev. Immunol. 5, 953–964 (2005).
Kuwana, M. et al. Human circulating CD14+ monocytes as a source of progenitors that exhibit mesenchymal cell differentiation. J. Leukoc. Biol. 74, 833–845 (2003).
Schmidt, M. et al. Identification of circulating fibrocytes as precursors of bronchial myofibroblasts in asthma. J. Immunol. 171, 380–389 (2003).
Haudek, S. B. et al. Bone marrow-derived fibroblast precursors mediate ischemic cardiomyopathy in mice. Proc. Natl Acad. Sci. USA 103, 18284–18289 (2006).
Varcoe, R. L. et al. The role of the fibrocyte in intimal hyperplasia. J. Thromb. Haemost. 4, 1125–1133 (2006).
Sakai, N. et al. Secondary lymphoid tissue chemokine (SLC/CCL21)/CCR7 signaling regulates fibrocytes in renal fibrosis. Proc. Natl Acad. Sci. USA 103, 14098–14103 (2006).
Cowper, S. E. et al. Nephrogenic fibrosing dermopathy. Am. J. Dermatopathol. 23, 383–393 (2001).
Aiba, S. & Tagami, H. Inverse correlation between CD34 expression and proline-4-hydroxylase immunoreactivity on spindle cells noted in hypertrophic scars and keloids. J. Cutan. Pathol. 24, 65–69 (1997).
Postlethwaite, A. E. et al. Cellular origins of fibroblasts: possible implications for organ fibrosis in systemic sclerosis. Curr. Opin. Rheumatol. 16, 733–738 (2004).
Nimphius, W. et al. CD34+ fibrocytes in chronic cystitis and noninvasive and invasive urothelial carcinomas of the urinary bladder. Virchows. Arch. 450, 179–185 (2007).
Barth, P. J. et al. CD34+ fibrocytes in neoplastic and inflammatory pancreatic lesions. Virchows. Arch. 440, 128–133 (2002).
Gerhardt, H. & Betsholtz, C. Endothelial-pericyte interactions in angiogenesis. Cell Tissue Res. 314, 15–23 (2003).
Sundberg, C. et al. Pericytes as collagen-producing cells in excessive dermal scarring. Lab. Invest. 74, 452–466 (1996).
Kalluri R. & Neilson, E. G. Epithelial–mesenchymal transition and its implications for fibrosis. J. Clin. Invest. 112, 1776–1784 (2003).
Zeisberg, M. et al. Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition. J. Biol. Chem. 282, 23337–23347 (2007).
Frid, M. G. et al. Mature vascular endothelium can give rise to smooth muscle cells via endothelial–mesenchymal transdifferentiation: in vitro analysis. Circ. Res. 90, 1189–1196 (2002).
Zeisberg, E. M. et al. Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat. Med. 13, 952–961 (2007).
Bataille, F. et al. Evidence for a role of epithelial mesenchymal transition during pathogenesis of fistulae in Crohn's disease. Inflamm. Bowel Dis. 7, 226–236 (2008).
Kumar, R. K. et al. Role of interleukin-13 in eosinophil accumulation and airway remodelling in a mouse model of chronic asthma. Clin. Exp. Allergy 32, 1104–1111 (2002).
Kolodsick, J. E. et al. Protection from fluorescein isothiocyanate-induced fibrosis in IL-13-deficient, but not IL-4-deficient, mice results from impaired collagen synthesis by fibroblasts. J. Immunol. 172, 4068–4076 (2004).
Zhu, Z. et al. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J. Clin. Invest. 103, 779–788 (1999).
Fichtner-Feigl, S. et al. IL-13 signaling through the IL-13alpha2 receptor is involved in induction of TGF-beta1 production and fibrosis. Nat. Med. 12, 99–106 (2006).
Fichtner-Feigl, S. et al. Induction of IL-13 triggers TGF-beta1-dependent tissue fibrosis in chronic 2, 4, 6-trinitrobenzene sulfonic acid colitis. J. Immunol. 178, 5859–5870 (2007).
Wynn, T. A. et al. An IL-12-based vaccination method for preventing fibrosis induced by schistosome infection. Nature 376, 594–596 (1995).
Gurujeyalakshmi, G. & Giri, S. N. Molecular mechanisms of antifibrotic effect of interferon gamma in bleomycin-mouse model of lung fibrosis: downregulation of TGF-beta and procollagen I and III gene expression. Exp. Lung Res. 21, 791–808 (1995).
Keane, M. P. et al. IL-12 attenuates bleomycin-induced pulmonary fibrosis. Am. J. Physiol. Lung Cell. Mol. Physiol. 281, L92–L97 (2001).
Spencer, D. M. et al. Distinct inflammatory mechanisms mediate early versus late colitis in mice. Gastroenterology 122, 94–105 (2002).
Bamias, G. et al. Proinflammatory effects of TH2 cytokines in a murine model of chronic small intestinal inflammation. Gastroenterology 128, 654–666 (2005).
Wynn, T. A. Cellular and molecular mechanisms of fibrosis. J. Pathol. 214, 199–210 (2008).
Hata, K. et al. IL-17 stimulates inflammatory responses via NF-κB and MAP kinase pathways in human colonic myofibroblasts. Am. J. Physiol. 282, G1035–G1044 (2002).
Papadakis, K. A. & Targan, S. R. The role of chemokines and chemokine receptors in mucosal inflammation. Inflamm. Bowel Dis. 6, 303–313 (2000).
Sato, M. et al. Targeted disruption of TGF-beta1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction. J. Clin. Invest. 112, 1486–1494 (2003).
Clouthier, D. E. et al. Hepatic fibrosis, glomerulosclerosis, and a lipodystrophy-like syndrome in PEPCK-TGF-beta1 transgenic mice. J. Clin. Invest. 100, 2697–2713 (1997).
Sime, P. J. et al. Adenovector-mediated gene transfer of active transforming growth factor-beta1 induces prolonged severe fibrosis in rat lung. J. Clin. Invest. 100, 768–776 (1997).
Gorelik, L. & Flavell, R. A. Transforming growth factor-beta in T-cell biology. Nat. Rev. Immunol. 2, 46–53 (2002).
Letterio, J. J. & Roberts, A. B. Regulation of immune responses by TGF-beta. Annu. Rev. Immunol. 16, 137–161 (1998).
Babyatsky, M. W. et al. Expression of transforming growth factors alpha and beta in colonic mucosa in inflammatory bowel disease. Gastroenterology 110, 975–984 (1996).
Motomura, Y. et al. Induction of a fibrogenic response in mouse colon by overexpression of monocyte chemoattractant protein 1. Gut 55, 662–670 (2006).
Sartor, R. B. Microbial influences in inflammatory bowel diseases. Gastroenterology 134, 577–594 (2008).
Fiocchi, C. Immune–nonimmune cell interactions: the other crosstalk between innate and adaptive immunity. In Recent Advances in Inflammatory Bowel Disease, 29–35 (Ed. Hibi T) Tokyo: Elsevier (2007).
Medzhitov, R. Origin and physiological roles of inflammation. Nature 454, 428–435 (2008).
Kanneganti, T. D. et al. Intracellular NOD-like receptors in host defense and disease. Immunity 27, 549–559 (2007).
Pierer, M. et al. Chemokine secretion of rheumatoid arthritis synovial fibroblasts stimulated by Toll-like receptor 2 ligands. J. Immunol. 172, 1256–1265 (2004).
Otte, J. M. et al. Intestinal myofibroblasts in innate immune responses of the intestine. Gastroenterology 124, 1866–1878 (2003).
Mourelle, M. et al. Stimulation of transforming growth factor beta1 by enteric bacteria in the pathogenesis of rat intestinal fibrosis. Gastroenterology 114, 519–526 (1998).
van Tol, E. A. et al. Bacterial cell wall polymers promote intestinal fibrosis by direct stimulation of myofibroblasts. Am. J. Physiol. 277, G245–G255 (1999).
Grassl, G. A. et al. Chronic, enteric salmonella infection in mice leads to severe and persistent intestinal fibrosis. Gastroenterology 134, 768–780 (2008).
Abreu, M. T. et al. Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease. Gastroenterology 123, 679–688 (2002).
Abreu, M. T. et al. Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease. Gastroenterology 123, 679–688 (2002).
Jiang, D. et al. Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nat. Med. 11, 1173–1179 (2005).
Schor, H. et al. Modulation of leukocyte behavior by an inflamed extracellular matrix. Dev. Immunol. 7, 227–238 (2000).
Alon, R. et al. TNF-alpha binds to the N-terminal domain of fibronectin and augments the beta 1-integrin-mediated adhesion of CD4+ T lymphocytes to the glycoprotein. J. Immunol. 152, 1304–1313 (1994).
Hershkoviz, R. et al. Disaccharides generated from heparan sulphate or heparin modulate chemokine-induced T-cell adhesion to extracellular matrix. Immunology 99, 87–93 (2000).
Vaday, G. G. et al. Fibronectin-bound TNF-alpha stimulates monocyte matrix metalloproteinase-9 expression and regulates chemotaxis. J. Leukoc. Biol. 68, 737–747 (2000).
Rieder, F. et al. Wound healing and fibrosis in intestinal disease. Gut 56, 130–139 (2007).
Danese, S. et al. Angiogenesis blockade as a new therapeutic approach to experimental colitis. Gut 56, 855–862 (2007).
Higgins, P. D. et al. Computed tomographic enterography adds information to clinical management in small bowel Crohn's disease. Inflamm. Bowel Dis. 13, 262–268 (2007).
Lawrance, I. C. et al. A murine model of chronic inflammation-induced intestinal fibrosis down-regulated by antisense NF-κB. Gastroenterology 125, 1750–1761 (2003).
Acknowledgements
The authors acknowledge the support of the Deutsche Forschungsgemeinschaft, Germany (F Rieder), and of the National Institutes of Health, Bethesda, MD, USA (C Fiocchi), and the technical assistance of J Kanasz, Cleveland Clinic Foundation, in illustrating this manuscript. The authors also acknowledge the contributions of several other colleagues whose work could not be cited due to space limitations.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Rieder, F., Fiocchi, C. Intestinal fibrosis in IBD—a dynamic, multifactorial process. Nat Rev Gastroenterol Hepatol 6, 228–235 (2009). https://doi.org/10.1038/nrgastro.2009.31
Issue Date:
DOI: https://doi.org/10.1038/nrgastro.2009.31
This article is cited by
-
Role of pH-sensing receptors in colitis
Pflügers Archiv - European Journal of Physiology (2024)
-
Adherent invasive Escherichia coli (AIEC) strain LF82, but not Candida albicans, plays a profibrogenic role in the intestine
Gut Pathogens (2021)
-
Betulinic acid hydroxamate prevents colonic inflammation and fibrosis in murine models of inflammatory bowel disease
Acta Pharmacologica Sinica (2021)
-
Comparative transcriptome and microbiota analyses provide new insights into the adverse effects of industrial trans fatty acids on the small intestine of C57BL/6 mice
European Journal of Nutrition (2021)
-
A literature-based approach for curating gene signatures in multifaceted diseases
Journal of Translational Medicine (2020)